Please provide your email address to receive an email when new articles are posted on . A point-of-care troponin test could reduce time patients with a heart attack spend in the ED by nearly 45 ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

One of the biggest daily challenges faced by healthcare providers is obtaining accurate diagnostic answers in a timely manner. Clinicians spend years training in physical diagnosis, mastering ...

A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...

Chronic kidney disease (CKD) affects over 800 million people globally and is often diagnosed too late for effective intervention. Early detection depends on accurate measurement of biomarkers such as ...

LONDON--(BUSINESS WIRE)--The global point-of-care coagulation testing market is poised to grow by USD 1 billion during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Request ...

Boston Easy Biotech has secured $2 million in early-stage funding to accelerate clinical validation and production of its microfluidic blood-testing platform. The investment will advance the company’s ...

This pilot study evaluates a newly developed point-of-care (PoC) device designed to measure bilirubin levels in human blood serum using a microfluidic cartridge and optoelectronic sensing module.